{
  "docId": "019dd923-5e88-73ef-bd5d-0856e1444fb9",
  "docSlug": "8757f1b44ef7f176",
  "documentTitle": "2024 Air Street Capital The State of AI Report 2024",
  "authorId": "AirStreetCapital",
  "authorName": "Air Street Capital",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "vc_research",
  "sourceTypeLabel": "VC research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 46,
  "pageCount": 213,
  "prevPage": 45,
  "nextPage": 47,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 12,
  "notes": "Includes a technical architecture diagram and a bar chart comparing success rates of AF3 against baselines.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "flowchart",
    "bar_chart_grouped"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5d-0856e1444fb9/46",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5d-0856e1444fb9",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5d-0856e1444fb9.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5d-0856e1444fb9#slide-46",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "DeepMind and Isomorphic Labs released AlphaFold 3, their successor from AF2, which can now model how small molecule drugs, DNAs, RNAs and antibodies interact with protein targets.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-47c3-7407-8d13-e03b29944a37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.4,
        "x": 0.55,
        "y": 0.53
      },
      "kind": "chart",
      "text": "Performance comparison chart for Ligands PoseBusters set and Nucleic acids",
      "attrs": null,
      "subkind": "bar-grouped",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d1348c7-68ff-45ae-a17b-2a1b9a034ad8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.4,
        "x": 0.55,
        "y": 0.33
      },
      "kind": "diagram",
      "text": "AlphaFold 3 architecture diagram",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aaa32b25-f97c-4114-a1a5-f43b89215b69",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.03,
        "y": 0.75
      },
      "kind": "list",
      "text": "Notably, no open-source code was made available (yet). Several independent groups are working on reproducing the work openly.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4acaef1b-c7f8-4f42-b7c2-2f5dbf5100c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.03,
        "y": 0.33
      },
      "kind": "list",
      "text": "There were substantial and surprising algorithmic changes from AF2: all equivariance constraints were removed in favor of simplicity and scale, while the Structure Module was replaced with a diffusion model to build the 3D coordinates.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "51a713f6-2b6a-4128-b961-8b4a43c94d02",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.03,
        "y": 0.55
      },
      "kind": "list",
      "text": "Unsurprisingly, the researchers claim that AF3 performs exceptionally well in comparison to other methods (esp. for small molecule docking), although this was not compared to stronger baselines.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe75cdf2-0918-45a7-9a1f-547894028091",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "Success (%)",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-47c3-7407-8d13-e6aac777ff26",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.5,
        "x": 0.03,
        "y": 0.22
      },
      "kind": "paragraph",
      "text": "DeepMind and Isomorphic Labs released AlphaFold 3, their successor from AF2, which can now model how small molecule drugs, DNAs, RNAs and antibodies interact with protein targets.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a0bf3f41-0285-4810-9e66-d54ad574c72e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.8,
        "x": 0.03,
        "y": 0.14
      },
      "kind": "title",
      "text": "AlphaFold 3: going beyond proteins and their interactions with other biomolecules",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9b6a5512-62a7-4d4f-977c-eb2a170e7482",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "019dd95a-1055-74e0-a958-ea7c3317c5f4",
      "evidence": "Title 'AlphaFold 3: going beyond proteins...'",
      "confidence": 85
    },
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "9d883fa6-ed3c-4059-8e2d-208d5d762c29",
      "evidence": "Performance comparison chart for Ligands PoseBusters set and Nucleic acids",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 153,
      "from": 9,
      "beatId": "019dd95a-0682-776c-8e35-5f2398b8d1d0",
      "arcName": "The Triple Take",
      "arcSlug": "triple-take",
      "beatName": "The Facts (What)",
      "beatSlug": "triple-take-the-facts-what",
      "evidence": "Exec summary + Research + Industry sections inventory the year",
      "position": 1,
      "confidence": 78,
      "parentBeatName": "Setup",
      "parentBeatSlug": "setup"
    },
    {
      "to": 85,
      "from": 12,
      "beatId": "019dd95a-0682-776c-8e35-6d9d8ee06d0a",
      "arcName": "Voyage and Return",
      "arcSlug": "voyage-return",
      "beatName": "The Unknown",
      "beatSlug": "voyage-return-the-unknown",
      "evidence": "Research section explores frontier model uncharted territory",
      "position": 2,
      "confidence": 55,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 58,
      "from": 45,
      "name": "Zoom In",
      "slug": "06-zoom-in",
      "bestFor": "Technical deep-dives, case studies, detailed analysis",
      "matchId": "019dd95a-07fe-70ce-8d3e-3bc439910222",
      "evidence": "Nobels, AlphaFold3, AlphaProteo, ESM3, gene editors, materials, brain fMRI, speech-from-cortex case studies",
      "position": 7,
      "objective": "Zoom into AI for science domain by domain",
      "structure": "The Big Picture -> Key Area of Focus -> Specific Detail -> Implication",
      "confidence": 80,
      "description": "Start broad, then progressively focus on specific details that prove your point"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}